Guyana vs Panama: Antiretroviral therapy coverage for PMTCT
Guyana
84.0%
in 2024
Panama
86.0%
in 2024
Guyana rank
37th
Panama rank
34th
Antiretroviral therapy coverage for PMTCT over time
- Guyana
- Panama
How they compare
Panama currently reports 86.0% against 84.0% in Guyana, a difference of 2.0%.
The two have swapped places 10 times across 25 shared years of data; in 2000 it was Panama ahead.
Guyana ranks 37th and Panama ranks 34th of 84 countries.
Panama has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Guyana | Panama | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 38.9% | 41.4% | 2.5% | Panama |
| 2010s | 74.6% | 77.7% | 3.1% | Panama |
| 2020s | 80.0% | 85.0% | 5.0% | Panama |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Guyana or Panama?
- Panama, at 86.0% against 84.0% in Guyana as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Guyana and Panama?
- 2.0%, with Panama ahead.
- How many years of comparable data are there for Guyana and Panama?
- 25 years are reported by both, from 2000 to 2024.
- How do Guyana and Panama rank globally for antiretroviral therapy coverage for pmtct?
- Guyana ranks 37th and Panama ranks 34th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).